Table 2 Characteristics of participants ≥15 years with confirmed pulmonary TB in Lwak and Kibera study sites in Kenya, 2011–2014
Lwak | Kibera | ||||
|---|---|---|---|---|---|
| Â | From home screeninga | From facility-based screeningb | From home screeninga | From facility-based screeningb | Total |
N = 18 | N = 28 | N = 14 | N = 41 | N = 101 | |
n(%) | n(%) | n(%) | n(%) | n(%) | |
Mean age | 51 | 41 | 34 | 33 | 37 |
 (Min – max) | (23–77) | (21–56) | (24–54) | (19–59) | 19–77 |
Gender | |||||
 Male | 7 (38.9) | 16 (57.1) | 5 (35.7) | 23 (56.1) | 51 (50.5) |
HIV status | |||||
 Positive | 6 (33.3) | 24 (85.7) | 6 (42.9) | 19 (46.3) | 55 (54.5) |
 Negative | 4 (22.2) | 3 (10.7) | 3 (21.4) | 16 (39.0) | 26 (25.7) |
 Unknown | 8 (44.4) | 1 (3.6) | 5 (35.7) | 6 (14.6) | 20 (19.8) |
Socioeconomic statusc | |||||
 Low | 9 (50.0) | 5 (17.9) | – | – | 14/46 (30.4) |
 Middle | 4 (22.2) | 16 (57.1) | – | – | 20/46 (43.5) |
 High | 5 (27.8) | 6 (21.4) | – | – | 11/46 (23.9) |
 Not available | 0 (0) | 1 (3.6) | – | – | 1/46 (2.2) |
Previous history of TBd | 4 (22.2) | – | 3 (21.4) | – | 7/32 (21.9) |
Symptoms reported | |||||
 Cough | 16 (88.9) | 20 (71.4) | 9 (64.3) | 30 (73.2) | 75 (74.3) |
 Fever | 3 (16.7) | 15 (53.6) | 6 (42.9) | 6 (14.6) | 30 (29.7) |
 Night sweats | 6 (33.3) | 8 (28.6) | 5 (35.7) | 5 (12.2) | 24 (23.8) |
 Weight loss | 4 (22.2) | 7 (25.0) | 5 (35.7) | 5 (12.2) | 21 (20.8) |
Duration of symptomse | |||||
  ≤ 2 weeks | 14 (77.8) | – | 8 (57.1) | – | 22 (21.8) |
  > 2 weeks | 4 (22.2) | – | 6 (42.9) | – | 10 (9.9) |
Coinfectionsf | |||||
 Positive blood culture | – | 2/13 (15.4) | – | – | 2/13 (15.4) |
 Positive malaria smear | – | 1/16 (6.3) | – | 1/1 (100) | 2/17 (11.8) |
Smear positive TB | 9 (50) | 10 (35.7) | 8 (57.1) | 23 (56.1) | 50 (49.5) |
MoH Notified | 18 (100) | 28 (100) | 14 (100) | 41 (100) | 101 (100) |
Referred to TB clinic | 18 (100) | 28 (100) | 14 (100) | 41 (100) | 101 (100) |